Literature DB >> 27028508

Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia.

Bei Wang1, Ling Lin2, Chang Zhao2.   

Abstract

OBJECTIVE: To investigate the related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia.
METHODS: One hundred and ten patients with primary hypertension and hyperhomocysteinemia (homocysteine levels >10 μmol/L) were enrolled into this study, ages from 18 years to 75 years. They were divided into the normal serum uric acid group which contained 74 cases patients (41 cases of male and 33 cases of female) and the hyperuricemia group which contained 36 cases patients (20 cases of male and 16 cases of female). Plasma concentrations of homocysteine, serum uric acid, serum folic acid, blood sugar, triglyceride, total cholesterol, serum low density lipoprotein cholesterol, serum high density lipoprotein cholesterol, blood urea nitrogen, and creatinine were detected in these patients, and the deference of them between the two groups was compared. And then the risk factors of serum uric acid with univariate analysis and multivariate analysis by logistic regression analysis were analyzed.
RESULTS: The result of multivariate analysis showed that the incidence of serum uric acid in patients with primary hypertension and hyperhomocysteinemia had significant relationships with systolic blood pressure (OR [odds ratio]: 1.132, 95%CI [confidence interval]: 1.003~1.290, p = 0.043), diastolic blood pressure (OR: 1.353 95%CI: 1.023~1.789, p = 0.034, homocysteine (OR: 1.264, 95%CI: 1.016~1.573, p = 0.035), triglyceride (OR: 9.726, 95%CI: 1.288~73.466, p = 0.027), and creatinine (OR: 1.031, 95%CI: 1.005~1.508, p = 0.018).
CONCLUSION: The indices of systolic blood pressure, diastolic blood pressure, homocysteine, triglyceride, and creatinine were important risk factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia. It is of great significance to measure multiple risk factors in patients with primary hypertension and hyperhomocysteinemia.

Entities:  

Keywords:  Hyperhomocysteinemia; hypertension; hyperuricemia; risk factors; serum uric acid

Mesh:

Substances:

Year:  2016        PMID: 27028508     DOI: 10.3109/10641963.2015.1107088

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  6 in total

1.  Diagnostic Value of Hcy Combined with Blood Pressure Variability Index in the Severity of Hypertension Complicated with CSVD and Its Correlation with Cognitive Function and CysC Expression.

Authors:  Qiaoling Liu; Xia Liu; Xuelian Zhang; Chen Zhou
Journal:  J Healthc Eng       Date:  2022-04-14       Impact factor: 3.822

2.  Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.

Authors:  Zhiwei Zhou; Kai Song; Jing Qiu; Yiying Wang; Chunxing Liu; Hui Zhou; Yunfang Xu; Zhirong Guo; Biao Zhang; Chen Dong
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

3.  Prevalence of hyperuricemia and its related risk factors among preschool children from China.

Authors:  Nan Li; Shuang Zhang; Weiqin Li; Leishen Wang; Huikun Liu; Wei Li; Tao Zhang; Gongshu Liu; Yuexin Du; Junhong Leng
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

4.  Diagnostic Values of Serum Levels of Homocysteine and Uric Acid for Predicting Vascular Mild Cognitive Impairment in Patients with Cerebral Small Vessel Disease.

Authors:  Ting Wang; Zhong-Wu Sun; Liang-Qing Shao; Xiao-Bin Xu; Yang Liu; Mao Qin; Xiang Weng; Yong-Xiang Zhang
Journal:  Med Sci Monit       Date:  2017-05-10

5.  Chronic lifestyle diseases display seasonal sensitive comorbid trend in human population evidence from Google Trends.

Authors:  Jai Chand Patel; Pankaj Khurana; Yogendra Kumar Sharma; Bhuvnesh Kumar; Sugadev Ragumani
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

6.  The Different Relationship between Homocysteine and Uric Acid Levels with Respect to the MTHFR C677T Polymorphism According to Gender in Patients with Cognitive Impairment.

Authors:  Hee-Jin Kim; Il Woong Sohn; Young Seo Kim; Jae-Bum Jun
Journal:  Nutrients       Date:  2020-04-19       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.